These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22739)

  • 1. l-Bunolol and propranolol: oral and intravenous beta-adrenoceptor blocking activity in rats compared to dogs and humans.
    Kaplan HR; Commarato MA; Lattime EC
    J Pharm Sci; 1978 Jan; 67(1):132-3. PubMed ID: 22739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levo-bunolol and propranolol: further evaluation of oral beta-blocking activity in conscious dogs.
    Commarato MA; Giardino EC; Kopia GA; Kaplan HR
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):205-13. PubMed ID: 327960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR; Commarato MA
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.
    Truelove JF; van Petten GR; Willes RF
    Br J Pharmacol; 1973 Jan; 47(1):161-71. PubMed ID: 4146153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. 2. Aromatic-substituted analogs of bunolol.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1973 Mar; 16(3):254-7. PubMed ID: 4147388
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivative of 3,4-dihydro-1(2H)-naphthalenone as -adrenergic blocking agents. 3. Carbonyl-containing analogs of bunolol.
    Schwender CF; Pike RE; Sunday BR; Shavel J
    J Med Chem; 1973 May; 16(5):585-8. PubMed ID: 4146254
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
    Himori N; Izumi A; Ishimori T
    Am J Physiol; 1980 May; 238(5):F387-93. PubMed ID: 6103674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the bronchoconstrictor and beta-adrenoceptor blocking activity of propranolol and acebutolol.
    MacLagan J; Ney UM
    Br J Pharmacol; 1980 Feb; 68(2):196-8. PubMed ID: 6101978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic comparison of L-bunolol with propranolol, metoprolol, and placebo.
    Ochs HR; Bahrmann H; Greenblatt DJ; Labedzki L
    J Clin Pharmacol; 1988 Dec; 28(12):1101-5. PubMed ID: 2907520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.